Literature DB >> 1635624

Clinical and cerebral blood flow studies in patients with intracranial hemorrhage and amyloid angiopathy typical of Alzheimer's disease.

H M Mehdorn1, L Gerhard, S P Müller, H M Olbrich.   

Abstract

Spontaneous intracerebral hemorrhages can occur in patients with severe amyloid angiopathy and other morphological signs of Alzheimer's disease (AD). We observed 15 patients in whom histological examination of brain tissue specimens obtained at surgery revealed characteristic congophilic amyloid deposits in subcortical arteries and/or nerve cells. Clinical follow-up examinations were carried out up to 9 years after diagnosis. In addition, three survivors from the operated group were investigated by neuropsychological testing and single photon emission computer tomography (SPECT) using Tc-99m-HMPAO for determination of regional cerebral blood flow (rCBF). SPECT could not differentiate between the "typical Alzheimer disease pattern" of bilateral temporo-parietal rCBF reduction and flow deficits resulting from previous hemorrhage. Intellectual functioning was found to be impaired to various degrees ranging from normal function to severe dementia (MMS test scores varied between 15 and 26 points); again, it was difficult to differentiate clinically between the nosologic entities mentioned above. On the basis of our present experience we cannot distinguish between brain dysfunction due to Alzheimer's disease and intracranial hemorrhage from amyloid angiopathy. This supports the idea that intracranial hemorrhage may only be one clinical manifestation of amyloid deposits, another one being "Alzheimer's disease" with varying preponderance.

Entities:  

Mesh:

Year:  1992        PMID: 1635624     DOI: 10.1007/bf00313505

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  9 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  The clinical diagnosis of Alzheimer's disease.

Authors:  J P Wade; T R Mirsen; V C Hachinski; M Fisman; C Lau; H Merskey
Journal:  Arch Neurol       Date:  1987-01

3.  [Vascular changes in Alzheimer's disease].

Authors:  L Gerhard; M Bergener; S Homayun
Journal:  Z Neurol       Date:  1972

Review 4.  Diaschisis.

Authors:  D M Feeney; J C Baron
Journal:  Stroke       Date:  1986 Sep-Oct       Impact factor: 7.914

5.  The incidence of cerebral amyloid angiopathy in Alzheimer's disease.

Authors:  T I Mandybur
Journal:  Neurology       Date:  1975-02       Impact factor: 9.910

6.  Vascular dementia and dementia of the Alzheimer type. Cognition, ventricular size, and leuko-araiosis.

Authors:  J Aharon-Peretz; J L Cummings; M A Hill
Journal:  Arch Neurol       Date:  1988-07

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123.

Authors:  K A Johnson; S T Mueller; T M Walshe; R J English; B L Holman
Journal:  Arch Neurol       Date:  1987-02

9.  Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity.

Authors:  K A Johnson; B L Holman; S P Mueller; T J Rosen; R English; J S Nagel; J H Growdon
Journal:  Arch Neurol       Date:  1988-04
  9 in total
  2 in total

1.  Subarachnoid hemorrhage of unknown origin. Longterm prognosis.

Authors:  H M Mehdorn; U Dietrich; R Kalff; B Hoffmann; F Rauhut; W Grote
Journal:  Neurosurg Rev       Date:  1992       Impact factor: 3.042

Review 2.  Impact of the biological definition of Alzheimer's disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?

Authors:  S Gauthier; H Zhang; K P Ng; T A Pascoal; P Rosa-Neto
Journal:  Transl Neurodegener       Date:  2018-05-31       Impact factor: 8.014

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.